Takuma Hayashi | Oncology Pharmaceuticals | Best Researcher Award

Takuma Hayashi | Oncology Pharmaceuticals | Best Researcher Award

Prof. Dr. Takuma Hayashi, National Hospital Organization Kyoto Medical Center, Japan

Prof. Dr. Takuma Hayashi is a renowned Japanese physician-scientist specializing in gynecologic oncology. 🎓 He earned his PhD from the University of Tokyo and trained at MIT’s Whitehead Institute 🧠, contributing to Nobel-linked research. Currently a professor at Shinshu University and Section Head at Kyoto Medical Center 🏥, his groundbreaking work on uterine leiomyosarcoma (LMS) identified LMP2 deficiency as a key biomarker 🔎. Through precision medicine and genomic profiling 🧬, his research has significantly advanced diagnostics and treatment strategies for LMS. With over 30 years of funded research, Dr. Hayashi is globally recognized for revolutionizing women’s cancer care.

Publication Profile

Scopus

Education

Prof. Dr. Takuma Hayashi is a distinguished physician-scientist known for bridging fundamental cancer research with clinical applications. 👨‍⚕️🔬 He is a Professor at Shinshu University Graduate School of Medicine and Section Head at Japan’s National Hospital Organization Kyoto Medical Center. 🎓🏥 Dr. Hayashi earned his PhD from the University of Tokyo and completed postdoctoral training at MIT’s Whitehead Institute under Dr. Rick A. Young. 🎓🇯🇵🇺🇸 He contributed to Nobel Prize-linked AIDS vaccine research with Dr. David Baltimore. With over 30 years of NIH and JSPS funding, his work focuses on molecular research in uterine leiomyosarcoma and ovarian cancer, collaborating with Nobel Laureate Dr. Susumu Tonegawa.

Experience

Prof. Dr. Takuma Hayashi has pioneered precision medicine breakthroughs in uterine leiomyosarcoma (LMS) treatment. 🧬💉 His team used cancer genome panel testing to tailor therapies based on each tumor’s unique genetics. For example, immunotherapy with pembrolizumab led to significant tumor regression, while targeted treatment with pazopanib stabilized disease for months. 🎯💊 Dr. Hayashi’s background from the University of Tokyo and MIT supports his innovative approach. 🚀 His ongoing goals include developing diagnostics, launching clinical trials, expanding global collaboration, and improving patient access to genomic profiling. 🌍💡 His work offers new hope for women facing this aggressive cancer.

Research Focus

Prof. Dr. Takuma Hayashi’s research primarily focuses on molecular oncology and infectious diseases, particularly cancer biomarkers and viral infections. 🧬🔬 His work on uterine leiomyosarcoma involves discovering key diagnostic biomarkers like LMP2 to improve early detection and treatment strategies in aggressive cancers. 🩺🎗️ Additionally, Dr. Hayashi explores infectious diseases such as avian influenza and COVID-19, emphasizing the One Health approach to prevent viral spread between animals and humans. 🦠🌍 His interdisciplinary research bridges cancer biology, immunology, and public health, aiming to develop precision medicine therapies and enhance global disease control efforts.

Publication Top Notes

THE ROLE OF LIVE BIRD MARKETS SHOULD BE EMPHASIZED IN PREVENTING THE SPREAD OF HIGHLY PATHOGENIC AVIAN INFLUENZA INFECTIONS

THE IMPORTANCE OF ONE HEALTH IN PREVENTING THE SPREAD OF HIGHLY PATHOGENIC AVIAN INFLUENZA/H5N1

Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer

DEVELOPMENT OF ENDOSALPINGIOSIS IN PATIENTS WITH A HISTORY OF BREAST CANCER

High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study

POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY

Assoc Prof Dr. Shereen ElAzzazy|Oncology Pharmaceuticals|Best Researcher Award

Assoc Prof Dr. Shereen ElAzzazy|Oncology Pharmaceuticals|Best Researcher Award

Assoc Prof Dr. Shereen ElAzzazy at HMC, QU, WHO,Qatar

PROFILE  

orcid

Google scholar

Early Academic Pursuits 🎓

The foundation of this individual’s career is rooted in a strong academic background. Although specific details about early education are not mentioned, the advanced roles undertaken in both pharmaceutical and medical sectors suggest a deep understanding and expertise in pharmacology, clinical pharmacy, and sterile medication preparation. Their professional journey likely began with formal education in pharmacy, complemented by continuous professional development and specialized training. The fact that they were entrusted with high-responsibility roles, such as acting pharmacy director, regulatory manager, and clinical instructor, indicates a robust educational foundation coupled with a commitment to lifelong learning.

Their association with the SAAD Training Institute, affiliated with Duke University, is an important academic highlight. This affiliation points to their exposure to global standards in pharmaceutical education and practices, which undoubtedly shaped their approach to teaching and developing competencies within their professional network.

Professional Endeavors 🏥

SAAD Specialist Hospital, Saudi Arabia (Dec 2003 – Jun 2006)
This phase of the career showcases the breadth and depth of their professional experience in Saudi Arabia’s healthcare system, particularly within SAAD Specialist Hospital, a prominent medical institution. Initially starting as a Pediatric Clinical Pharmacist in 2003, they quickly rose through the ranks to take on more senior and specialized roles.

  • Education and Development Coordinator (Dec 2005 – Jun 2006): In this role, they focused on the educational advancement of the hospital’s healthcare professionals. This position required overseeing staff training and ensuring adherence to the latest pharmaceutical guidelines and practices, fostering an environment of continual learning and improvement.
  • Aseptic Technology Instructor, SAAD Training Institute (Jun 2004 – Jun 2006): As an instructor, they were responsible for training both pharmacists and non-pharmacists in aseptic techniques, particularly in the preparation of sterile medications. The affiliation with Duke University highlights the high standard of education and training delivered.
  • IV Room Supervisor (Jun 2004 – Jun 2006): Managing the IV Room, they oversaw sterile medication preparation for neonates, pediatric, and adult patients, dealing with complex formulations such as Total Parenteral Nutrition (TPN), chemotherapy drugs, and desensitization protocols.

These roles reflect a strong command over clinical pharmacy, sterile practices, and pharmaceutical education, making them a critical contributor to healthcare improvement in Saudi Arabia.

Governmental Hospital of Tropical Diseases, Ministry of Health, Egypt (Dec 1997 – Dec 2003)
Their role at this governmental hospital in Egypt demonstrates significant leadership and management skills within the pharmaceutical services sector.

  • Inpatient Pharmacist (Dec 1997 – Sep 2002): During this period, they were entrusted with the pharmaceutical care of inpatient services, managing medication therapy and ensuring safe medication administration.
  • Acting Pharmacy Director (Oct 2002 – Dec 2003): As Acting Pharmacy Director, they assumed full authority over the hospital’s pharmacy operations. This role required balancing clinical duties with administrative responsibilities, overseeing drug inventories, ensuring compliance with pharmaceutical regulations, and leading the pharmacy staff.

This progression in Egypt’s healthcare sector speaks to their competence, leadership abilities, and the trust placed in them to manage essential healthcare operations.

CBIC Medical, Pharmaceutical Development, and Consultation Company (Nov 2002 – Dec 2003)
In parallel with their role in Egypt’s healthcare system, they also held a position in CBIC Medical, which involved regulatory and marketing responsibilities in the pharmaceutical sector.

  • Regulatory and Marketing Manager: They were tasked with navigating complex pharmaceutical regulations while overseeing the marketing of medical products. This role required a deep understanding of both the regulatory landscape and market dynamics.
  • Clinical and Marketing Instructor: Leveraging their extensive pharmaceutical knowledge, they conducted training programs for medical representatives, teaching them about new products and re-launched products, as well as imparting advanced marketing strategies.

This role illustrates their ability to work across both clinical and commercial spheres, bridging the gap between product development, regulatory compliance, and market outreach.

Contributions and Research Focus 🔬

While explicit research endeavors are not mentioned, their extensive work in teaching, sterile medication preparation, and regulatory roles highlights a career deeply rooted in evidence-based practices. Their focus on educating healthcare professionals in critical areas like aseptic techniques and sterile medication preparation indicates a dedication to improving healthcare outcomes through rigorous training.

The supervisory roles in sterile medication preparation, particularly for vulnerable populations such as neonates and pediatric patients, point to a keen interest in precision pharmacy and patient safety, areas likely to have been influenced by research in clinical pharmacology.

Accolades and Recognition 🏅

The trust and leadership roles assigned to them—ranging from being an Acting Pharmacy Director to a supervisor and instructor at the SAAD Specialist Hospital—reflect the high regard in which they were held by their peers and employers. Their instructional role at the SAAD Training Institute, affiliated with Duke University, is a significant marker of their expertise and the recognition they received in the field of pharmaceutical education.

Impact and Influence 🌍

Their influence spans multiple facets of healthcare, particularly in the realms of education, clinical pharmacy, and sterile medication practices. Through teaching roles, both at SAAD and CBIC Medical, they shaped the competencies of numerous healthcare professionals, directly impacting patient safety and care quality.

As a supervisor in the preparation of sterile medications, they ensured that some of the most vulnerable patients—neonates and those undergoing chemotherapy—received safe, effective treatments. This role would have had a profound impact on patient outcomes, underscoring their influence in clinical settings.

Legacy and Future Contributions 📜

Their legacy is marked by the high standards of training and education they provided, particularly in aseptic techniques and sterile medication preparation. The knowledge they imparted to medical representatives and pharmacy staff will continue to influence healthcare practices long after their direct involvement.

🎓Publication 

Patterns of onset and resolution of immune‐related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced …

  • Authors   :Jeffrey S Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F Stephen Hodi, MDX010‐20 Investigators
  • Journal    : Cancer
  • Year         :2013

An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital

  • Authors   :Eva Rämme Bremberg, Christina Hising, Urban Nylén, Hans Ehrsson, Staffan Eksborg
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2006

The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy

  • Authors   : Ahmet S Boşnak, Nevzat Birand, Ömer Diker, Abdikarim Abdi, Bilgen Başgut
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2019

Denosumab in hypercalcemia of malignancy: a case series

  • Authors   : Amanda Dietzek, Kelly Connelly, Michael Cotugno, Sylvia Bartel, Anne M McDonnell
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2015

Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis

  • Authors   :Sha Li, Tsz-him So, Guoyi Tang, Hor-Yue Tan, Ning Wang, Bacon Fung Leung Ng, Chris Kam Wa Chan, Edwin Chau-Leung Yu, Yibin Feng
  • Journal    :Frontiers in Oncology
  • Year         :2020

Assoc Prof Dr. Sanli Jin| Oncology Pharmaceuticals |Best Researcher Award

Assoc Prof Dr. Sanli Jin|Oncology Pharmaceuticals|Best Researcher Award

Assoc Prof Dr. Sanli Jin at Peking University School of Nursing,China

PROFILE  

scopus

Early Academic Pursuits 🎓

Sanli Jin embarked on her academic journey at Peking University, one of the most prestigious institutions in China. After joining the School of Nursing in 2004, she pursued her doctoral degree with a specific focus on oncology and nutrition nursing, surgical nursing, and nursing simulation. Her early years of academic training at Peking University provided her with a strong foundation in both theoretical knowledge and practical skills. This combination of educational rigor and practical exposure positioned her to become a leader in the field of nursing education in China.

Professional Endeavors 👩‍🏫

Since completing her doctoral studies, Sanli Jin has been an integral member of the School of Nursing at Peking University, where she serves as an Associate Professor. Her professional work spans various aspects of nursing education, including her involvement in the development and promotion of artificial intelligence-assisted learning methods. Sanli’s teaching excellence has been acknowledged through her role in managing and leading virtual and in-person simulation projects. These projects aim to improve the critical thinking and practical skills of undergraduate nursing students, setting a new standard for nursing education across China.

Sanli has also been actively involved in several key research initiatives, including the development of multimodal teaching methods for diseases of the urinary system and an in-depth study of nutrition-related symptoms in cancer patients undergoing radiotherapy. Through these contributions, she has gained recognition as a leading voice in nursing research and innovation, not only in China but also internationally.

Research and Contributions 📚

Sanli Jin’s research focuses primarily on three main areas: oncology and nutrition nursing, surgical nursing, and nursing simulation. Her contributions in these areas have significantly influenced both clinical practice and education. A key component of her research involves exploring the relationship between nutritional status and patient outcomes in oncology, particularly for patients with head and neck cancers. Her work in this domain has provided valuable insights into managing the complex nutritional needs of cancer patients, and she has earned awards for her research contributions, such as the Second Prize of the Beijing Nursing Society Science and Technology Award.

Another notable aspect of her work is in nursing simulation. Sanli has designed numerous simulation scenarios aimed at enhancing student learning, with her work receiving accolades such as the First Prize in the Case Group of the “Ninth Peking University Innovative Teaching and Learning Application Competition.” These contributions highlight her commitment to improving the quality of nursing education and equipping future nurses with the tools they need to succeed in complex clinical environments.

Accolades and Recognition 🏆

Over her career, Sanli Jin has been the recipient of multiple awards recognizing both her teaching excellence and her contributions to nursing research. Among her most notable accolades are:

  • National First Class Undergraduate Online Course: An award that highlights her contributions to the development of innovative, high-quality online nursing education.
  • Second Prize of the Beijing Nursing Society Science and Technology Award (Technical Achievement Award): Recognizing her work in the nutritional management of cancer patients.
  • Teaching Excellence Award from Peking University Health Science Center: A testament to her commitment to nursing education and student development.

In addition to these awards, Sanli has published nearly 100 papers in prominent national and international journals, further cementing her reputation as a researcher. Her work has garnered 389 citations and earned her an h-index of 11, showcasing the impact and influence of her research within the academic community.

Impact and Influence 🌍

Sanli Jin’s influence extends beyond her individual achievements in research and education. Her work in oncology nursing has had a profound impact on improving patient care, particularly for cancer patients undergoing radiotherapy. Through her research on nutrition and cancer, she has contributed to a better understanding of how dietary interventions can improve patient outcomes. Her efforts have also advanced simulation-based learning in nursing, bridging the gap between theoretical knowledge and practical skills for future generations of nurses.

Her leadership extends to various professional organizations as well. As a member of the MDT Professional Committee for Head and Neck Tumors and the Youth Committee for Cancer Rehabilitation and Nursing, Sanli actively collaborates with other professionals to push the boundaries of nursing science. These memberships allow her to continue influencing the field of oncology nursing, contributing to new standards and best practices.

Legacy and Future Contributions 🌱

Sanli Jin’s contributions have set a strong foundation for the future of nursing in China, particularly in the fields of oncology, nutrition, and nursing simulation. As a pioneer in incorporating artificial intelligence into nursing education, she has paved the way for future generations to embrace technology as a tool for enhancing both learning and patient care. Her ongoing research projects, such as the exploration of virtual simulation’s impact on nursing education, position her at the forefront of innovative teaching methods.

Her legacy is not just one of research and education but also of mentorship and leadership. Sanli has played a key role in nurturing the next generation of nurses and healthcare professionals, instilling in them the values of critical thinking, innovation, and compassion. Her commitment to advancing the field of nursing through both educational initiatives and patient care improvements ensures that her influence will continue to resonate for years to come.

Conclusion 📝

Sanli Jin’s academic and professional journey reflects a deep commitment to improving both nursing education and patient care. From her early academic pursuits to her innovative contributions in research and teaching, she has become a recognized leader in the field of nursing. Her work has not only earned her multiple prestigious awards but has also left a lasting impact on both her students and the broader nursing community. As she continues to explore new avenues of research and education, her legacy as a visionary in nursing will continue to grow, shaping the future of healthcare in China and beyond.

🎓Publication 

Evaluation of the combination of virtual simulation and in-person simulation among undergraduate nursing students: A mixed methods study

  • Authors   : Han, F., Jin, S.
  • Journal    :Nurse Education in Practice
  • Year         :2024

Body composition and dietary intake in patients with head and neck cancer during radiotherapy: A longitudinal study

  • Authors   :Zhuang, B., Zhang, L., Wang, Y., Jin, S., Lu, Q.
  • Journal    :BMJ Supportive and Palliative Care,
  • Year         :2023

Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy

  • Authors   : Wang, Y., Zhang, L., Zhang, T., Sun, Y., Lu, Q.
  • Journal    :Head and Neck
  • Year         :2023

Routine replacement versus replacement as clinical indicated of peripheral intravenous catheters: A multisite randomised controlled trial

  • Authors   : Li, J., Ding, Y., Lu, Q., Lyu, Y., Lin, F.
  • Journal    :Journal of Clinical Nursing,
  • Year         :2023.

Association between body composition and survival in head and neck cancer patients undergoing radiotherapy

  • Authors   : Zhuang, B., Xiao, S., Zhang, L., Sun, Y., Lu, Q.
  • Journal    :Head and Neck,
  • Year         :2022

Assist Prof Dr. Ali Tavakoli|Oncology Pharmaceuticals|Best Researcher Award-1234

Assist Prof Dr. Ali Tavakoli,Oncology Pharmaceutical,Best Researcher Award

Assist Prof Dr. Ali Tavakoli, at Shiraz University of Medical Sciences,Iran

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Dr. Ali Tavakoli embarked on his distinguished academic journey by earning his Medical Doctor (MD) degree from Shiraz University of Medical Sciences in Shiraz, Iran, in 1998. His early academic pursuits were marked by a profound interest in the complexities of the human body and the desire to contribute to medical science. This foundational phase was not just about acquiring knowledge but also about laying the groundwork for a career dedicated to improving health outcomes.

He continued his academic journey with a Master in Public Health (MPH) from the same institution in 2007. His MPH thesis, which focused on investigating risk factors of low birth weight in newborns, underlined his commitment to addressing public health issues. The meticulous work conducted under the supervision of Dr. Mohammad Hadi Imanieh showcased his analytical skills and dedication to maternal and child health.

🩺Professional Endeavors :

Dr. Tavakoli’s professional career has been a blend of clinical practice, administrative roles, and academic contributions. As an Assistant Professor in the Department of Persian Medicine at Shiraz University of Medical Sciences, he has been instrumental in advancing the field of traditional medicine. His role involves not only teaching but also mentoring students and conducting groundbreaking research.

Between May 2020 and November 2021, he served as the Advisor to the Chancellor of Shiraz University of Medical Sciences, a role that emphasized his leadership and strategic planning abilities. His involvement in significant projects, such as the national food security project in Zarrin Dasht County and the national MMR vaccination project, highlights his dedication to public health initiatives.

📚Contributions and Research Focus :

Dr. Tavakoli’s research has significantly contributed to various fields, including traditional Persian medicine, public health, and clinical trials. His Ph.D. thesis, supervised by Dr. Seyed Alireza Taghavi, evaluated the effect of Rose (Rosa damascena mill L) Oil Soft Capsules on clinical outcomes in ulcerative colitis, showcasing his innovative approach to integrating traditional remedies with modern clinical practices.

His extensive list of publications, including studies on the quality of work life and human resource productivity, the effects of medicinal plants on clinical conditions, and the efficacy of traditional treatments, reflects his diverse research interests and his ability to bridge traditional and modern medicine. Notable publications include:

  • “Efficacy of Rose Oil Soft Capsules on Clinical Outcomes in Ulcerative Colitis: A Pilot Randomized, Double-Blinded, Placebo-Controlled Clinical Trial” (Galen Medical Journal, 2019)
  • “COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study” (Iranian Journal of Medical Sciences, 2023)
  • “Efficacy of Plantago major leaf extract cream in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial” (European Journal of Integrative Medicine, 2023)

🏆Accolades and Recognition :

Dr. Tavakoli’s excellence has been recognized through various awards and honors. He was the top student in the Traditional Persian Medicine Ph.D. comprehensive exam at Shiraz University of Medical Sciences in 2014 and the top Ph.D. graduate in 2012. In 2010, he was awarded as the Annual Best Staff at Shiraz University of Medical Sciences, reflecting his outstanding contributions to the institution.

🌟Impact and Influence :

Dr. Tavakoli has had a profound impact on both his students and the broader medical community. His leadership roles, such as being a member of the Executive Committee of the Shiraz International mHealth Congress and his involvement with the Iranian Scientific Association of Traditional Medicine, have allowed him to influence the direction of medical research and public health policies.

🌍Legacy and Future Contributions :

Dr. Tavakoli’s legacy is characterized by his commitment to integrating traditional Persian medicine with contemporary clinical practices. His work has paved the way for future research in this field, promoting a holistic approach to healthcare. His ongoing research and publications continue to influence and inspire new generations of medical professionals.

In the future, Dr. Tavakoli aims to expand his research into the global applications of traditional Persian medicine, contributing to international medical knowledge and practices. His dedication to education, research, and public health ensures that his contributions will have a lasting impact on the medical community and beyond.

🎓Publication 

Reporting of adverse effects of pomegranate in clinical studies: a systematic review

  • Authors   :Hamid Zare, Ehsan Amiri Ardekani, Ali Tavakoli, Ryan Bradley, Fatemeh Tavakoli, Mehdi Pasalar
  • Journal    :Journal of Complementary and Integrative Medicine
  • Year         : 2024

Radiodermatitis in the field of traditional Persian medicine; a narrative review

    • Authors :Ghazaleh Heydarirad, Bahareh Ahadi, Ali Tavakoli, Hamid Reza Mirzaei, Mojgan Mehri Ardestani, Shaghayegh Kamian, Mehdi Pasalar
    • Journal   :Annals of the Romanian Society for Cell Biology
    • Year       : 2021

World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017

  • Authors  :, Kyung-Eun Choi, Lisha He, Han Wang, X He, C Gu, Y Zhang, Linhua Zhao, Xiaolin Tong, Lisha He, Han Wang, Xinhui He, Chengjuan Gu, Ying Zhang, Linhua Zhao, Xiaolin Tong, Lisha He
  • Journal    :BMC Complementary and Alternative Medicine
  • Year         :  2017

Efficacy of Plantago major leaf extract cream compared to placebo in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial

  • Authors  :Zahra Salehi, Ali Tavakoli, Seyed Hassan Hamedi, Soodabeh Samimi, Foroogh Namjooyan, Mansour Ansari, Hamid Nasrollahi, Nezhat Khanjani, Niloofar Ahmadloo, Ahmad Mosalaei, Behnam Kadkhodaei, Hossein Molavi Vardanjani, Mehrab Sayadi
  • Journal   :European Journal of Integrative Medicine
  • Year        :   2023

 

Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Authors  :Ghazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali TavakoliGhazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali Tavakoli
  • Journal   :Galen Medical Journal
  • Year        :   2021